Karyopharm Therapeutics Inc.

8-K Other events Jul 31, 2026 8-K Director or officer change Jul 17, 2026 8-K Director or officer change; Shareholder vote results May 28, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Other events Mar 27, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Mar 24, 2026 8-K Entered a material agreement; Other events Mar 3, 2026 8-K Shareholder vote results Feb 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 13, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Results of operations (earnings release); Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Oct 14, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Oct 8, 2025 8-K Director or officer change Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Regulation FD disclosure Jul 11, 2025 8-K Director or officer change; Shareholder vote results May 29, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Modified rights of security holders; Amended charter or bylaws Feb 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 19, 2025 8-K Results of operations (earnings release) Feb 19, 2025 8-K Director or officer change Jan 31, 2025 8-K Shareholder vote results Jan 30, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Director or officer change Jan 2, 2025 8-K Regulation FD disclosure Dec 3, 2024 8-K Director or officer change Nov 20, 2024 8-K Entered a material agreement Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Regulation FD disclosure; Other events Oct 31, 2024 8-K Delisting notice or listing-rule failure Sep 17, 2024 8-K Director or officer change Aug 29, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024